SCHEMBL6522561

SCHEMBL6522561

CCCCCCCCCCCCCCCCSCC(Nc1csc(C)n1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
PLA2G4A P47712 1/20 0.36
MAPT P10636 2/20 0.35
GMNN O75496 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35
CYP2C9 P11712 1/20 0.35
BLM P54132 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ICMT O60725 1/20 0.34
PTGES O14684 4/20 0.33
ALOX5 P09917 4/20 0.33
PPARG P37231 3/20 0.33
CES2 O00748 1/20 0.33
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6524114 0.79 RAB9A (0.41) LMNARAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL6518242 0.78 ICMT (0.38) MAPTGMNNTP53POLBTHRB
SCHEMBL6521511 0.78 GMNN (0.39) MAPTGMNNTP53POLBTHRB
SCHEMBL6521996 0.77 KDM4E (0.41) RAB9ASMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL6522607 0.76 KDM4E (0.46) RAB9ASMN1; SMN2ALDH1A1HPGDMAPT
SCHEMBL6524273 0.75 L3MBTL1 (0.43) LMNASMN1; SMN2ALDH1A1MAPTCYP2C9
SCHEMBL6521346 0.75 ALOX12 (0.47) LMNARAB9ASMN1; SMN2ALDH1A1POLB
SCHEMBL6520453 0.74 GMNN (0.40) MAPTGMNNTP53POLBTHRB
SCHEMBL6527550 0.74 HCAR3 (0.38) RAB9ASMN1; SMN2MAPTGMNNTP53
SCHEMBL6524196 0.73 ICMT (0.35) ALDH1A1HPGDMAPTGMNNTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE MPO, CYSLTR1, HNMT LMNA 4743/4885RAB9A 542/4885SMN1; SMN2 4449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.